Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Allakos Inc (NQ: ALLK )

104.50 -3.64 (-3.37%)
Official Closing Price Updated: 6:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Allakos Inc

< Previous 1 2 3 4 5 Next >
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting
From GlobeNewswire News Releases
RiverVest Venture Partners Closes $275 Million Life Sciences Fund
RiverVest Venture Partners, a leading venture capital firm, announced today the closing of its RiverVest Venture Fund V, L.P. (“Fund V”), with $275 million of capital commitments in an oversubscribed... 
From Business Wire News Releases
Allakos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allakos Appoints Natalie Holles to its Board of Directors
From GlobeNewswire News Releases
Allakos Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allakos Announces Presentation from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting
From GlobeNewswire News Releases
Allakos Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Allakos Previews Preliminary Financial Results for the Three Months Ended September 30, 2020
From GlobeNewswire News Releases
Allakos Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Allakos Announces Results from a Phase 1 Study of Subcutaneously Administered Lirentelimab (AK002)
From GlobeNewswire News Releases
Results from Prospective Prevalence Study Indicate that Eosinophilic Gastritis and Eosinophilic Duodenitis May be Significantly Underdiagnosed
From GlobeNewswire News Releases
Allakos Announces Publication of Results from the Phase 2 Study of Lirentelimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis (ENIGMA) in the New England Journal of Me
From GlobeNewswire News Releases
Allakos Reports Second Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allakos Initiates Patient Recruitment for AK002 Registrational Studies
From GlobeNewswire News Releases
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the Digital EAACI Annual Congress 2020
From GlobeNewswire News Releases
ALLAKOS FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors of Deadline Today In Securities Class Action First Filed by Firm – ALLK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through December 17, 2019, inclusive (the “Class Period”)... 
From Business Wire News Releases
Allakos Announces a Presentation of Antolimab in Patients with Severe Allergic Conjunctivitis at the 2020 ASCRS Virtual Annual Meeting
From GlobeNewswire News Releases
Allakos Reports First Quarter 2020 Financial Results
From GlobeNewswire News Releases
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALLK, CRON, FNKO Investors: 2-DAY APPLICATION DEADLINE ALERT, Investors with Losses Should Contact Firm Immediately
From GlobeNewswire News Releases
ALLAKOS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm
From GlobeNewswire News Releases
ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors that only 3 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc.
From GlobeNewswire News Releases
ALLAKOS FINAL DEADLINE, ROSEN, A TOP RANKED FIRM, Encourages Allakos Inc. Investors to Contact Firm Prior to May 11 Deadline For Class Action First Filed by Firm Seeking Recovery of Investor losses –
From GlobeNewswire News Releases
Allakos Class Action Reminder: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm
From NewMediaWire
ALLK DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020
From GlobeNewswire News Releases
Allakos Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm
From NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK
From GlobeNewswire News Releases
ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors That Only 5 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of... 
From Business Wire News Releases
NASDAQ: ALLK Shareholder Notice: Deadline on May 11, 2020 in Lawsuit Against Allakos Inc.
San Diego, CA -- (SBWIRE) -- 05/05/2020 -- A Deadline is coming up on May 11, 2020 in the lawsuit for certain investors in Allakos Inc. (NASDAQ: ALLK). 
From SBWire - Latest Press Releases
Allakos Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm
From NewMediaWire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALLK, CRON, FNKO Investors: 7-DAY APPLICATION DEADLINE ALERT, Investors with Losses Should Contact Firm
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]